For example, a 2011 study in rats found that the peptide successfully healed various lesions and promoted healthy weight gain in models of short-bowel syndrome.14 Additionally, as researchers note in the aforementioned 2016 review on BPC-157 and the gut-brain axis, BPC 157 was successful in the therapy of GI tract, periodontitis, liver and pancreas lesions, and in the healing of various tissues and wounds. Its also written in the review that the peptide acts as a mediator of Roberts cytoprotection, defined as the counteraction of the lesions arising from direct detrimental contact with a noxious agent.7 15 Insider Tip: Though there has been some small-scale positive human research on BPC-157, most of the peptides potential uses are based on the outcomes of animal or cell studies

This more than 50% decline in the body's principal tissue-regenerating peptide correlates directly with the decreased healing capacity, diminished collagen production, and compromised follicular function that characterize aging skin and scalp
Association between atazanavir-induced hyperbilirubinemia and cardiovascular disease in patients infected with HIV
McBride, 2011), implicitly suggesting that GSH depletion may take place also in other clinical settings